Trial Details
COMPLETEDBasic Information
| Clinical ID | c3095 |
|---|---|
| Identifier | NCT02538341 |
| Trial Title | Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Rheumatoid Arthritis|Inflammatory Arthritis|Arthritis|Psoriatic Arthritis|Psoriasis|Ankylosing Spondylitis|Enteropathic Arthritis|Crohn's Disease |
| Interventions | BIOLOGICAL: Herpes Zoster (HZ) Vaccine|DRUG: Placebo |
Participant Information
| Sponsor | University of Alabama at Birmingham |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2016-05 |
|---|---|
| Primary Completion Date | 2019-12 |
| Completion Date | 2020-12 |